LAVA Therapeutics NV (LVTX) — Capital Reinvestment Ratio
LAVA Therapeutics NV (LVTX) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow ($35.73 Million) in capital expenditures ($265.00K). Check LVTX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
LAVA Therapeutics NV Capital Reinvestment Ratio (2022–2022)
This chart tracks LAVA Therapeutics NV's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see LAVA Therapeutics NV (LVTX) cash conversion ratio.
Annual Capital Reinvestment Ratio for LAVA Therapeutics NV (2022–2022)
Year-by-year Capital Reinvestment Ratio for LAVA Therapeutics NV from 2022 to 2022. See LAVA Therapeutics NV free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.15x | $4.04 Million | $587.00K | — |